XML 114 R101.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Reporting - Reconciliation of Adjusted EBITDA (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Segment Reporting [Abstract]    
Net loss attributable to common shareholders of Evolent Health, Inc. $ (9,807) $ (78,752)
Interest income 123 770
Interest expense (6,337) (6,281)
Provision for income taxes (611) (270)
Depreciation and amortization expenses (15,187) (15,978)
Equity method investment impairment 0 (47,133)
Gain on transfer of membership 22,969 0
Loss on repayment of debt, net (19,158) 0
Gain (loss) from equity method investees 7,783 (412)
Gain (loss) on disposal of assets 0 (6,447)
Change in fair value of contingent consideration and indemnification asset 594 3,818
Other expense, net (14) (70)
Repositioning costs (5,380) 0
Stock-based compensation expense (3,706) (3,508)
Severance costs (52) (6,103)
Amortization of contract cost assets (127) (440)
Strategy and shareholder advisory expenses (5,000) 0
Acquisition costs (1,994) (309)
Gain (loss) from discontinued operations [1] 1,383 (265)
Adjusted EBITDA $ 14,907 $ 3,876
[1] Includes $1.9 million gain on disposal of discontinued operations for the three months ended March 31, 2021